CCMH
CLVS

Cornerstone Capital Management Holdings’s Clovis Oncology, Inc. CLVS Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$1.21M Buy
17,733
+400
+2% +$28K 0.01% 865
2017
Q3 		$1.43M Hold
17,333
– – 0.01% 855
2017
Q2 		$1.62M Sell
17,333
-211
-1% -$12.9K 0.01% 794
2017
Q1 		$1.12M Buy
17,544
+16,344
+1,362% +$994K 0.01% 900
2016
Q4 		$52K Buy
1,200
+700
+140% +$24.6K ﹤0.01% 1276
2016
Q3 		$18K Buy
+500
New +$10.7K ﹤0.01% 1324
2015
Q4 		– Sell
-3,200
Closed -$294K – 1556
2015
Q3 		$294K Buy
3,200
+800
+33% +$69.2K ﹤0.01% 1141
2015
Q2 		$211K Buy
2,400
+200
+9% +$17.1K ﹤0.01% 1185
2015
Q1 		$163K Buy
2,200
+700
+47% +$49.4K ﹤0.01% 1210
2014
Q4 		$84K Buy
1,500
+700
+88% +$36.8K ﹤0.01% 1179
2014
Q3 		$36K Buy
+800
New +$33.4K ﹤0.01% 1227

Other funds holding CLVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Cornerstone Capital Management Holdings's CLVS Position: Q4 2017 in Review

Cornerstone Capital Management Holdings increased its Clovis Oncology, Inc. (CLVS) stake by 2.3% in Q4 2017, buying an estimated $28K and bringing the position to 17,733 shares worth $1.21M. The position accounts for 0.01% of the portfolio, ranked #865.

Cornerstone Capital Management Holdings first reported a position in CLVS in Q3 2014 and has held it in 11 quarters since. The position peaked at $1.62M in Q2 2017. 247 funds tracked by Wall St. Rank hold CLVS as of Q4 2017.

  • Cornerstone Capital Management Holdings held 17,733 shares of Clovis Oncology, Inc. worth $1.21M as of Q4 2017.
  • Cornerstone Capital Management Holdings bought 400 Clovis Oncology, Inc. shares in Q4 2017, an estimated $28K.
  • Clovis Oncology, Inc. made up 0.01% of Cornerstone Capital Management Holdings's portfolio in Q4 2017, its #865 holding.
  • Cornerstone Capital Management Holdings first reported a position in Clovis Oncology, Inc. in Q3 2014 and has held it in 11 quarters since.
  • Cornerstone Capital Management Holdings's Clovis Oncology, Inc. position peaked at $1.62M in Q2 2017.
  • 247 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2017.

Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2017, filed 14 Feb 2018.